Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
cabotegravir-rilpivirine
cabotegravir-rilpivirine
Brand names: Cabenuva
| Form | Strength |
|---|---|
| SUSPENSION, EXTENDED RELEASE, INTRAMUSCULAR |
VIEW MORE HIV Integrase Inhibitors, HIV Nonnucleoside Reverse Transcriptase Inhibitors
CLASS
CLASS
08180812, 08180816
Last updated: Feb. 22, 2023
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Restricted Formulary Restricted Medication
Cabotegravir-rilpivirine extended-release injectable (Cabenuva) is Formulary, Restricted to outpatient; Utilization of an oral lead-in prior to administration of cabotegravir-rilpivirine injection may help ensure patient-specific tolerability until more real-world data is available.